At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
World-Class OLED Material and Technology
Novaled GmbH, a leader in the organic light-emitting diode (OLED) field, specializes in high efficiency, long-lifetime OLED structures. With expertise in synthetic and analytical chemistry, we offer complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials.
Novaled has developed long-term partnerships with major OLED players worldwide. Our strong IP position in OLED technology is based on more than 500 patents granted or pending.
In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.